Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
192.2 GBX | -1.91% | -23.10% | -36.97% |
05-20 | Faron Pharmaceuticals’ Blood Cancer Combo Shows Efficacy in Mid-stage Study | MT |
05-20 | Faron Pharma celebrates positive read-out in ongoing MDS trial | AN |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-36.97% | 179M | |
+10.79% | 116B | |
+11.65% | 106B | |
-6.20% | 23.89B | |
-3.32% | 21.58B | |
-11.25% | 18.96B | |
-13.41% | 16.33B | |
-40.50% | 16.96B | |
+6.64% | 14.14B | |
+31.84% | 12.02B |
- Stock Market
- Equities
- FARN Stock
- News Faron Pharmaceuticals Oy
- Faron Pharmaceuticals Names New Chief Medical Officer